TP53 and carcinoma: Moreover, ADORA2B mRNA expression was significantly higher in LUAD tissues than in para-carcinoma tissues in subgroup analyses based on sample type, individual cancer stage, ethnicity, gender, age, smoking habits, nodal metastasis status, and TP53 mutation status (Figures 2A–H).